CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 106 enrolled
Drug / intervention
Actigraphother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03054441
NCT03054441N/ACompleted

Detection of Asymmetries in Upper Limb Use Through Actigraphs

IRCCS Fondazione Stella Maris·observational·Posted Feb 15, 2017·Updated Sep 14, 2018

In Brief

An observational study evaluating Actigraph for Hemiplegia and Hemiplegic Cerebral Palsy. Completed, enrolled 106 participants across 1 site.

Detailed Summary

In hemiplegia quantitatively measurement of the asymmetry in the use of upper limbs could overcome the limitation of many outcome measures in which scores are dependent on the experience and training of the therapist. The main aim of this study was to determine the validity of Actigraph GXT3+ to measure asymmetry in the use of the two upper limbs during the Assisting Hand Assessment (AHA) in children, adolescents and young with hemiplegia aged 5-19 years, compared to age-matched typically developing subjects (TD).

Study Details

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedFeb 15, 2017
Enrollment StartJan 1, 2017
Primary CompletionJul 1, 2018
Study CompletionSep 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.4 years ago

Interventions

Actigraphother

Actigraphs worn on wrists